"9th World Congress on Hypertension, Cardiology, Primary Health and Patient Care” cordially invites all participants across the globe to attend the Webinar on November 29-30, 2021. This two-day event will cover Keynote sessions of leading experts, plenary talks, and poster presentations of researchers and other academicians.
Euro Hypertension 2021 will lay a stage for all the researchers, elite professors, and cardiologists, nephrologists, endocrinologists, therapists, osteopathicians, bariatric, attendants, medical services experts to talk about a methodology for hypertension and finding, therapy and prevention of elevated blood pressure.
Hypertension is fairly common among the human population and is often unregulated; however, an uncontrolled increase in blood pressure leaves the individuals at risk to develop heart ailments. According to a report by the World Health Organization in 2018, 1.1 billion people in the world have raised blood pressure and less than 1 in 5 have it under control. Treatment of cardiovascular infection frequently requires the administration of various drugs for extensive stretches of time to patients prone to be old and experiencing a scope of co-dismal conditions. This Conference is dedicated to inciting discussions that promote innovations and fresh perspectives to the existing research related to cardiovascular diseases and hypertension.
Hypertension 2021 is a distinctive forum to assemble worldwide distinguished academics within the field of cardiology, nephropathy, neuropathy, endocrinology, psychiatry , public health professionals, scientists, educational scientists, industry researchers, scholars to exchange concerning state of the art analysis and provides the best chance to reach the biggest gathering of participants from round the world. Conduct displays, distribute and update information concerning the current state of affairs of hypertension treatment and their effects that leads to the downfall of the society. This 2-day event can surely profit and paves the way for the betterment of the globe. Broadly acclaimed speakers, the foremost recent researches and updates in hypertension are the key features of this event.
The benefits provided to the attendees are:
-
CME accreditation certificates will be provided to all speakers, delegates and students
-
Opportunity to meet the world’s renowned speakers at this event
-
Keynote forums by Prominent Physicians & Professors
-
Oral/Poster presentations by Young Researchers
-
Best poster award for students
This is how webinars have become the new normal. They are an extraordinary method to deal with your professional activities while keeping up social distancing. Although webinars are not a new discovery, there is a definite increase in their use and we see more and more conferences opting for this method to reach out to their participants.
In fact, according to a study conducted by GoToWebinars in 2019 (months before the coronavirus outbreak), a massive 73 percent had already started the use of webinars. Additionally, 57 percent of them have decided to continue creating more webinars in order to generate awareness. Fast forward to March 2020, the number of such online events hosted has increased by 330 percent, and the numbers of attendees are doubling with each passing month.
As per a statement of the World Health Organization (WHO), Hypertension is one of the silent killers in the 21st century and is one of the biggest global public health concerns. Hypertension is a major contributor to cardiac complications, stroke, heart diseases, kidney failure, blindness, including premature death and disabilities. Hypertension is curable as well as treatable for which there is a need for involvement from individual entities, government and private sectors, health workers, civil societies, and moreover individual awareness is highly recommended.
As per the estimation of WHO, globally more than 1.13 billion people are affected with Hypertension among which less than 1 in each 5 is under control. Unfortunate eating regimens, absence of physical exercises, utilization of liquor, and tobacco are the fundamental contributing elements of Hypertension. To lessen the predominance by 25% by 2025, WHO alongside the United States Center for Disease Control and Prevention dispatched the Global heart Initiative in 2016. Globally, Hypertension or High Blood Pressure leads to 7.5million death cases which share about 12.8% of all death cases recorded. Hypertension is also accounted for about 57million disabilities adjusted life years which is about 3.7% of total adjusted life years. Hypertension is the primary risk factor of coronary heart disease, ischemic & hemorrhagic stroke.
The global prevalence of Hypertension in adults aged>25 was about 40% in 2008. Between 1980 to 2008 the prevalence was moderate. But, due to the sharp growth in population, the aging population the uncontrolled Hypertension reached 1 billion in 2008 from 600 million. The prevalence of hypertension was highest in Africa (>40%) and lower in the Americas (35%).
As per the research of some independent firms, the global Hypertension drug market is estimated to be $24.7billion in 2018 & expected to hit about $19.3 billion by 2029 with an annual CAGR of -2.3% in between 2019 to 2029. The main Drugs in the Hypertension market are Tacleer, Uptravi, Opsumit, Letairis, Adcirca, Revatio, Adempas, Veletri, Oremitram, Tyvaso, Remodulin. Major classes of drugs used are Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin-Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors. Major players in the antihypertensive drugs market are: Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Sanofi Aventis, and United Therapeutics.
